Epidiolex derived from marijuana to treat epilepsy

The U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana. It … Read more

Patterns of medication nonadherence in epilepsy children linked to socioeconomic status

Patterns of Medication Nonadherence Among Children with Epilepsy Associated With Socioeconomic Status – An examination of medication adherence among children with newly diagnosed epilepsy found that nearly 60 percent showed persistent nonadherence during the first 6 months of therapy, and that lower socioeconomic status was associated with higher non-adherence.

Pay more attention to epilepsy, affects millions of people

Researchers: Pay more attention to epilepsy, affects millions of people – Epilepsy, a common and serious neurologic disorder that affects millions of people, is not getting the public attention and funding for research it deserves, according to an editorial on a study published in the January_4, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

MMRV vaccine linked to double risk of seizures

Combination MMRV vaccine linked with 2-fold risk of seizures — Electronic health records study of 459,000 children sparked new CDC recommendations – The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and the varicella (V) vaccine for chicken pox.

Do NOT follow this link or you will be banned from the site!